Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for Chronic Hepatitis C in HIV Infected Patients
NCT00246363Phase 2Completed
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis C virus infection comparing Silymarin with Placebo (2 arms). Primary endpoint: Progression of liver damage at 1 year. Started Jan 2005; status: completed.
02
Drugs
silymarin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00246363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246363.